DYNE THERAPEUTICS, INC.

Lobbying client · Massachusetts · filed 2026 to 2026

A biotechnology company developing nucleic acid therapies for rare diseases.

$40,000 Reported spend

2 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (72232), not by name.

Firms hired 1

W STRATEGIES, LLC $40,000 2 filings

Reported by year 1 year

2026 $40,000 2 filings

Issues lobbied 1

Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

HOUSE OF REPRESENTATIVES 1

Recent filings 2 total

Q2

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · $40,000 income · posted Jul 20, 2026

View → RR

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted Apr 7, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.